Article
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Seminars in oncology - 1 Jun 2014
Carr Brian I, Pancoska Petr, Giannini Edoardo G, Farinati Fabio, Ciccarese Francesca, Rapaccini Gian Ludovico, Marco Maria Di, Benvegnù Luisa, Zoli Marco, Borzio Franco, Caturelli Eugenio, Chiaramonte Maria, Trevisani Franco
Abstract excerpt
Previous work has shown that two general processes contribute to hepatocellular cancer (HCC) prognosis: liver damage, monitored by indices such as blood bilirubin, prothrombin time (PT), and aspartate aminostransferase (AST); and tumor biology, monitored by indices such as tumor size, tumor number, presence of portal vein thrombosis (PVT) and blood alpha-fetoprotein (AFP) levels. These processes may affect one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.